CSIMarket
 


X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 

Cumulative X4 Pharmaceuticals Inc's Total Debt to Equity for Trailing Twelve Months Period

XFOR's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

XFOR Total Debt to Equity for Trailing Twelve Months Period

(Mar 31 2024)
I. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -98.6 % 9.29 % 124.57 % 3.95 % 14.96 %
Y / Y Total Debt Growth - - -91.12 % -83.78 % 65.41 %
Total Debt to Equity for Trailing Twelve Months Period 0.01 0.01 0.07 0.12 0.13
Total Ranking # 3 # 8 # 17 # 134 #
Seq. Equity Growth -98.47 % 0.09 % 30.69 % -30.22 % 19.73 %
Seq. Total Debt Growth - - 37.91 % -57.87 % -91.01 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Mar 31 2024
On the trailing twelve months basis In the I. Quarter X4 Pharmaceuticals Inc did not have Total Debt .
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc achieved the lowest Total Debt to Equity for Trailing Twelve Months Period. While Total Debt to Equity for Trailing Twelve Months Period total ranking has improved so far to 3, from total ranking in previous quarter at 8.

What is Debt to Equity Ratio?
XFOR Charts and Quotes
Total Debt to Equity XFOR in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 0
Sector # 0
S&P 500 # 3


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.31 0.09 0
(Dec 31 2018)   (Sep 30 2021)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Mar 31 2024, within Biotechnology & Pharmaceuticals Industry Total Debt to Equity for Trailing Twelve Months Period
Windtree Therapeutics Inc  0.02 
Miromatrix Medical inc   0.02 
Inhibikase Therapeutics Inc   0.02 
X4 Pharmaceuticals Inc  0.01 
Recursion Pharmaceuticals Inc 0.00 
Ikena Oncology Inc 0.00 
Sophia Genetics Sa 0.00 
Iovance Biotherapeutics inc 0.00 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com